0000000000298203

AUTHOR

Omri Wolk

showing 3 related works from this author

Biowaiver Monographs for Immediate-Release Solid Oral Dosage Forms: Codeine Phosphate

2014

The present monograph reviews data relevant to applying the biowaiver procedure for the approval of immediate-release multisource solid dosage forms containing codeine phosphate. Both biopharmaceutical and clinical data of codeine were assessed. Solubility studies revealed that codeine meets the "highly soluble" criteria according to World Health Organization (WHO), the European Medicines Agency (EMA), and the United States Food and Drug Administration (US FDA). Codeine's fraction of dose absorbed in humans was reported to be high (>90%) based on cumulative urinary excretion of drug and drug-related material following oral administration. The permeability of codeine was also assessed to be …

Dosage FormsDrugCodeinebusiness.industrymedia_common.quotation_subjectCodeinePharmaceutical ScienceCodeine PhosphateBioequivalencePharmacologyDosage formBioavailabilityExcipientsBiopharmaceuticalSolubilityOral administrationmedicineHumansbusinessmedicine.drugmedia_commonJournal of Pharmaceutical Sciences
researchProduct

In-situ intestinal rat perfusions for human Fabs prediction and BCS permeability class determination: Investigation of the single-pass vs. the Doluis…

2015

Intestinal drug permeability has been recognized as a critical determinant of the fraction dose absorbed, with direct influence on bioavailability, bioequivalence and biowaiver. The purpose of this research was to compare intestinal permeability values obtained by two different intestinal rat perfusion methods: the single-pass intestinal perfusion (SPIP) model and the Doluisio (closed-loop) rat perfusion method. A list of 15 model drugs with different permeability characteristics (low, moderate, and high, as well as passively and actively absorbed) was constructed. We assessed the rat intestinal permeability of these 15 model drugs in both SPIP and the Doluisio methods, and evaluated the co…

In situMaleSingle passIntestinal permeabilitybusiness.industryPharmaceutical ScienceBioequivalencePharmacologymedicine.diseaseBiopharmaceutics Classification SystemModels BiologicalPermeabilityBioavailabilityRatsPerfusionPermeability (earth sciences)Intestinal AbsorptionPharmaceutical PreparationsmedicineAnimalsHumansIntestinal MucosaRats WistarbusinessPerfusionInternational journal of pharmaceutics
researchProduct

Oral drug therapy following bariatric surgery: an overview of fundamentals, literature and clinical recommendations

2016

Bariatric surgery is the most effective solution for severe obesity and obesity with comorbidities, and the number of patients going through bariatric surgery is rapidly and constantly growing. The modified gastrointestinal anatomy of the patient may lead to significant pharmacokinetic alterations in the oral absorption of drugs after the surgery; however, because of insufficient available literature and inadequate awareness of the medical team, bariatric surgery patients may be discharged from the hospital with insufficient instructions regarding their medication therapy. In this article, we aim to present the various mechanisms by which bariatric surgery may influence oral drug absorption…

medicine.medical_specialtybusiness.industryEndocrinology Diabetes and MetabolismPublic Health Environmental and Occupational HealthSevere obesity030226 pharmacology & pharmacyEffective solutionSurgery03 medical and health sciences0302 clinical medicinemedicineMedical team030212 general & internal medicinebusinessOral retinoidObesity Reviews
researchProduct